CCA
HAE icon

Checchi Capital Advisers’s Haemonetics HAE Stock Holding History

Checchi Capital Advisers’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-106
Closed -$3K – 744
2016
Q2 		$3K Hold
106
– – ﹤0.01% 1472
2016
Q1 		$4K Buy
+106
New +$3.42K ﹤0.01% 1444

Other funds holding HAE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

Checchi Capital Advisers's HAE Position: Q3 2016 in Review

Checchi Capital Advisers sold out of Haemonetics (HAE) in Q3 2016, closing a stake of 106 shares — an estimated $3K sold.

Checchi Capital Advisers first reported a position in HAE in Q1 2016 and held it in 2 quarters. The position peaked at $4K in Q1 2016. 181 funds tracked by Wall St. Rank hold HAE as of Q3 2016.

  • Checchi Capital Advisers reported no remaining Haemonetics position as of Q3 2016 after selling out during the quarter.
  • Checchi Capital Advisers sold 106 Haemonetics shares in Q3 2016, an estimated $3K.
  • Checchi Capital Advisers first reported a position in Haemonetics in Q1 2016 and held it in 2 quarters.
  • Checchi Capital Advisers's Haemonetics position peaked at $4K in Q1 2016.
  • 181 funds tracked by Wall St. Rank held Haemonetics as of Q3 2016.

Based on Checchi Capital Advisers's 13F filing for Q3 2016, filed 10 Nov 2016.